Imperva Surges on Sales Gains, Boosted Yearly Outlook

Updated on

Imperva Inc. gained the most in three months after boosting its yearly sales outlook and reporting second-quarter revenue that beat analysts’ estimates.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.